Comparison of gas chromatographic and high-performance liquid chromatographic assays for the determination of debrisoquine and its 4-hydroxy metabolite in human fluids.

A comparison of an established gas chromatographic assay for 4-hydroxydebrisoquine and debrisoquine and a modified high-performance liquid chromatographic assay was made. Both assays used guanoxan as the internal standard and required derivatization of all three compounds with acetylacetone at 96 degrees C for 2.5 h and subsequent ethereal extraction and cleaning steps before chromatographic analysis. For detailed pharmacokinetic studies the gas chromatographic assay was more sensitive in the measurement of low concentrations in plasma, but the liquid chromatographic assay was adequate for phenotyping the 4-hydroxylation of debrisoquine in a population. In the latter assay a mobile phase consisting of 70% methanol in water at pH 3.5 (adjusted with orthophosphoric acid containing 10 mM 1-pentanesulphonic acid was employed (flow-rate 1.5 ml/min) with a pre-column (C8) linked to a reversed-phase muBondapak C18 cartridge in a Z-module. The eluate was detected at 248 nm. With this assay it was observed that the buccal absorption of debrisoquine and 4-hydroxy-debrisoquine was affected by the pH of the buccal medium. This indicates that urinary pH may influence the excretion of both substances at high pH. The debrisoquine-to-4-hydroxydebrisoquine ratio may be dose-dependent.